Detection of responsible mutations for beta thalassemia in the Kermanshah Province of Iran using PCR-based techniques

被引:34
作者
Rahimi, Zohreh [1 ,2 ]
Muniz, Adriana [3 ]
Parsian, Abbas [4 ]
机构
[1] Kermanshah Univ Med Sci, Sch Med, Med Biol Res Ctr, Kermanshah, Iran
[2] Kermanshah Univ Med Sci, Sch Med, Dept Biochem, Kermanshah, Iran
[3] Albert Einstein Coll Med, Dept Physiol & Biophys, Div Hematol, Dept Med, Bronx, NY 10467 USA
[4] NIH, Div Neurosci & Behav, Rockville, MD USA
关键词
Beta thalassemia; Molecular analysis; Mutation; Western Iran; MOLECULAR CHARACTERIZATION; SOUTHERN IRAN; SPECTRUM; IDENTIFICATION; PREVENTION; PROGRAM;
D O I
10.1007/s11033-009-9560-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Beta Thalassemia has been reported to be a common genetic disorder in Iran. To establish the molecular spectrum of the beta thalassemias in the Kermanshah Province of Iran, 185 unrelated beta thalassemia patients with Kurdish ethnic background were studied (181 beta-thalassemia major and 4 beta-thalassemia intermedia). Using polymerase chain reaction-amplification refractory mutation system (PCR-ARMS), restriction fragment length polymorphism (RFLP) and direct genomic sequencing twenty different mutations were identified accounting for 98.1% of the alleles. Approximately 80.8% of beta-thalassemia chromosomes had beta(0) mutation. The most prevalent mutation was the IVSII-1 (G -> A) (32.97%), followed by CD8/9 +G (13.51%), IVSI-110 (C -> T) (8.38%), CD 36/37 -T (7.84%), CD8 -AA (5.94%), CD15 (G -> A) (4.86%) and IVSI-1 (G -> A) (4.59%). All of these mutations accounted for 78.1% of the alleles. The results described here will be of valuable help in the development of successful prevention programs for the population of Kermanshah.
引用
收藏
页码:149 / 154
页数:6
相关论文
共 27 条
[1]   Thalassemia in Iran - Epidemiology, prevention, and management [J].
Abolghasemi, Hassan ;
Amid, Ali ;
Zeinali, Sirous ;
Radfar, Mohammad H. ;
Eshghi, Peyman ;
Rahiminejad, Mohammad S. ;
Ehsani, Mohammad A. ;
Najmabadi, Hossein ;
Akbari, Mohammad T. ;
Afrasiabi, Abdolreza ;
Akhavan-Niaki, Haleh ;
Hoofar, Hamid .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 (04) :233-238
[2]   MOLECULAR CHARACTERIZATION OF ALPHA-THALASSEMIA DETERMINANTS, BETA-THALASSEMIA ALLELES, AND BETA(S) HAPLOTYPES AMONG KUWAITI ARABS [J].
ADEKILE, AD ;
GU, LH ;
BAYSAL, E ;
HAIDER, MZ ;
ALFUZAE, L ;
ABOOBACKER, KC ;
ALRASHIED, A ;
HUISMAN, THJ .
ACTA HAEMATOLOGICA, 1994, 92 (04) :176-181
[3]  
[Anonymous], 1971, Nonparametric Statistical Inference
[4]   ESTIMATION OF SMALL PERCENTAGES OF FOETAL HAEMOGLOBIN [J].
BETKE, K ;
MARTI, HR ;
SCHLICHT, I .
NATURE, 1959, 184 (4702) :1877-1878
[5]   Spectrum of β-thalassemia mutations in Oman [J].
Daar, S ;
Hussein, HM ;
Merghoub, T ;
Krishnamoorthy, R .
COOLEYS ANEMIA: SEVENTH SYMPOSIUM, 1998, 850 :404-406
[6]  
Derakhshandeh-Peykar P, 2008, IRAN J PUBLIC HEALTH, V37, P106
[7]   Distribution of β-thalassemia mutations in the northern provinces of Iran [J].
Derakhshandeh-Peykar, Pupak ;
Akhavan-Niaki, Haleh ;
Tamaddoni, Ahmad ;
Ghawidel-Parsa, Shohreh ;
Naieni, Kourosh Holakouie ;
Rahmani, Manijeh ;
Babrzadeh, Farbod ;
Dilmaghani-Zadeh, Mohammad ;
Farhud, Dariush Daneshvar .
HEMOGLOBIN, 2007, 31 (03) :351-356
[8]   MOLECULAR DEFECTS IN BETA-THALASSEMIAS IN THE POPULATION OF SAUDI-ARABIA [J].
ELHAZMI, MAF ;
ALSWAILEM, AR ;
WARSY, AS .
HUMAN HEREDITY, 1995, 45 (05) :278-285
[9]   A significant beta-thalassemia heterogeneity in the United Arab Emirates [J].
ElKalla, S ;
Mathews, AR .
HEMOGLOBIN, 1997, 21 (03) :237-247
[10]   An unusually frequent β-thalassemia mutation in an Iranian province [J].
Eshghi, Peyman ;
Zadeh-Vakili, Azita ;
Rashidi, Armin ;
Miri-Moghadam, Ebrahim .
HEMOGLOBIN, 2008, 32 (04) :387-392